Application Sponsors
ANDA 207321 | GLAND PHARMA LTD | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | 0 | DEXRAZOXANE HYDROCHLORIDE | DEXRAZOXANE HYDROCHLORIDE |
002 | INJECTABLE;INJECTION | EQ 250MG BASE/VIAL | 0 | DEXRAZOXANE HYDROCHLORIDE | DEXRAZOXANE HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2016-11-28 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AP |
002 | Prescription | AP |
CDER Filings
GLAND PHARMA LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 207321
[companyName] => GLAND PHARMA LTD
[docInserts] => ["",""]
[products] => [{"drugName":"DEXRAZOXANE HYDROCHLORIDE","activeIngredients":"DEXRAZOXANE HYDROCHLORIDE","strength":"EQ 500MG BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"DEXRAZOXANE HYDROCHLORIDE","activeIngredients":"DEXRAZOXANE HYDROCHLORIDE","strength":"EQ 250MG BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"11\/28\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2016-11-28
)
)